Accessory-cell-mediated activation of porcine NK cells by toll-like receptor 7 (TLR7) and TLR8 agonists

Clinical and Vaccine Immunology

Volumn 16, Issue 6, 2009, Pages 866-878

  Toka, Felix N ^a,b   Nfon, Charles K ^a   Dawson, Harry ^c   Golde, William T ^a  

^a PLUM ISLAND ANIMAL DISEASE CENTER   (United States)

^b WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

^c AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR ALPHA; INTERLEUKIN 18; MESSENGER RNA; PERFORIN; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR AGONIST; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ACCESSORY CELL; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG PROTEIN BINDING; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; INNATE IMMUNITY; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SWINE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; FOOT-AND-MOUTH DISEASE VIRUS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; PERFORIN; SWINE; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 8;

EID: 67249131643     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00035-09     Document Type: Article

References (50)

1. Adams, S., D. W. O'Neill, D. Nonaka, E. Hardin, L. Chiriboga, K. Siu, C. M. Cruz, A. Angiulli, F. Angiulli, E. Ritter, R. M. Holman, R. L. Shapiro, R. S. Berman, N. Berner, Y. Shao, O. Manches, L. Pan, R. R. Venhaus, E. W. Hoffman, A. Jungbluth, S. Gnjatic, L. Old, A. C. Pavlick, and N. Bhardwaj. 2008. Immunization of malignant melanoma patients with full-length N.Y.-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant. J. Immunol. 181:776-784.
2. Bautista, E. M., G. S. Ferman, and W. T. Golde. 2003. Induction of lymphopenia and inhibition of T cell function during acute infection of swine with foot and mouth disease virus (FMDV). Vet. Immunol. Immunopathol. 92:61-73.
3. Boyiadzis, M., S. Memon, J. Carson, K. Allen, M. J. Szczepanski, B. A. Vance, R. Dean, M. R. Bishop, R. E. Gress, and F. T. Hakim. 2008. Upregulation of NK cell activating receptors following allogeneic hematopoietic stem cell transplantation under a lymphodepleting reduced intensity regimen is associated with elevated IL-15 levels. Biol. Blood Marrow Transplant. 14:290-300.
4. Brown, M. G., A. O. Dokun, J. W. Heusel, H. R. Smith, D. L. Beckman, E. A. Blattenberger, C. E. Dubbelde, L. R. Stone, A. A. Scalzo, and W. M. Yokoyama. 2001. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 292:934-937. (Pubitemid 32422491)
5. Cantell, K., and J. Pirhonen. 1996. IFN-γ enhances production of IFN-α in human macrophages but not in monocytes. J. Interferon Cytokine Res. 16:461-463. (Pubitemid 26195746)
6. Chalifour, A., P. Jeannin, J. F. Gauchat, A. Blaecke, M. Malissard, T. N'Guyen, N. Thieblemont, and Y. Delneste. 2004. Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers alpha-defensin production. Blood 104:1778-1783. (Pubitemid 39202287)
7. Doherty, T. M., R. A. Seder, and A. Sher. 1996. Induction and regulation of IL-15 expression in murine macrophages. J. Immunol. 156:735-741. (Pubitemid 26028932)
8. + cells mediate the antitumor effects of a dual Toll-like receptor 7/8 agonist in the disseminated B16-F10 melanoma model. Cancer Immunol. Immunother. 58:575-587.
9. Fernandez, N. C., A. Lozier, C. Flament, P. Ricciardi-Castagnoli, D. Bellet, M. Suter, M. Perricaudet, T. Tursz, E. Maraskovsky, and L. Zitvogel. 1999. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat. Med. 5:405-411.
10. Fitzgerald, P., and C. Lopez. 1986. Natural killer cells active against viral, bacterial, protozoan and fungal infections, p. 107-111. In E. Lotzova and R. B. Herberman (ed.), Immunobiology of natural killer cells, vol.2. CRC Press, Boca Raton, FL.
11. Forsbach, A., J. G. Nemorin, C. Montino, C. Muller, U. Samulowitz, A. P. Vicari, M. Jurk, G. K. Mutwiri, A. M. Krieg, G. B. Lipford, and J. Vollmer. 2008. Identification of RNA sequence motifs stimulating sequence-specific TLR8-dependent immune responses. J. Immunol. 180:3729-3738.
12. Girart, M. V., M. B. Fuertes, C. I. Domaica, L. E. Rossi, and N. W. Zwirner. 2007. Engagement of TLR3, TLR7, and NKG2D regulate IFN-γ secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12. J. Immunol. 179:3472-3479.
13. Golde, W. T., J. M. Pacheco, H. Duque, T. Doel, B. Penfold, G. S. Ferman, D. R. Gregg, and L. L. Rodriguez. 2005. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: use in emergency outbreak response. Vaccine 23:5775-5782. (Pubitemid 41668884)
14. Gorden, K. B., K. S. Gorski, S. J. Gibson, R. M. Kedl, W. C. Kieper, X. Qiu, M. A. Tomai, S. S. Alkan, and J. P. Vasilakos. 2005. Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8. J. Immunol. 174:1259-1268.
15. Gorski, K. S., E. L. Waller, J. Bjornton-Severson, J. A. Hanten, C. L. Riter, W. C. Kieper, K. B. Gorden, J. S. Miller, J. P. Vasilakos, M. A. Tomai, and S. S. Alkan. 2006. Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists. Int. Immunol. 18:1115-1126.
16. Grubman, M. J., and B. Baxt. 2004. Foot-and-mouth disease. Clin. Microbiol. Rev. 17:465-493.
17. Hart, O. M., V. Athie-Morales, G. M. O'Connor, and C. M. Gardiner. 2005. TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-γ production. J. Immunol. 175:1636-1642. (Pubitemid 41023066)
18. Hyodo, Y., K. Matsui, N. Hayashi, H. Tsutsui, S. Kashiwamura, H. Yamauchi, K. Hiroishi, K. Takeda, Y. Tagawa, Y. Iwakura, N. Kayagaki, M. Kurimoto, H. Okamura, T. Hada, H. Yagita, S. Akira, K. Nakanishi, and K. Higashino. 1999. IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor. J. Immunol. 162:1662-1668. (Pubitemid 29307043)
19. Jinushi, M., T. Takehara, T. Kanto, T. Tatsumi, V. Groh, T. Spies, T. Miyagi, T. Suzuki, Y. Sasaki, and N. Hayashi. 2003. Critical role of MHC class I-related chain A and B expression on IFN-α-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection. J. Immunol. 170:1249-1256. (Pubitemid 36139490)
20. Jinushi, M., T. Takehara, T. Tatsumi, T. Kanto, V. Groh, T. Spies, T. Suzuki, T. Miyagi, and N. Hayashi. 2003. Autocrine/paracrine IL-15 that is required for type I IFN-mediated dendritic cell expression of MHC class I-related chain A and B is impaired in hepatitis C virus infection. J. Immunol. 171:5423-5429. (Pubitemid 37432829)
21. Kamath, A. T., C. E. Sheasby, and D. F. Tough. 2005. Dendritic cells and NK cells stimulate bystander T cell activation in response to TLR agonists through secretion of IFN-α/β and IFN-γ. J. Immunol. 174:767-776. (Pubitemid 40094271)
22. Lanier, L. L. 2005. NK cell recognition. Annu. Rev. Immunol. 23:225-274.
23. Lauzon, N. M., F. Mian, R. MacKenzie, and A. A. Ashkar. 2006. The direct effects of Toll-like receptor ligands on human NK cell cytokine production and cytotoxicity. Cell. Immunol. 241:102-112.
24. Lee, S. H., T. Miyagi, and C. A. Biron. 2007. Keeping NK cells in highly regulated antiviral warfare. Trends Immunol. 28:252-259. (Pubitemid 46810349)
25. Leulier, F., and B. Lemaitre. 2008. Toll-like receptors - taking an evolutionary approach. Nat. Rev. Genet. 9:165-178.
26. Liese, J., U. Schleicher, and C. Bogdan. 2007. TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis. Eur. J. Immunol. 37:3424-3434.
27. Mandelboim, O., N. Lieberman, M. Lev, L. Paul, T. I. Arnon, Y. Bushkin, D. M. Davis, J. L. Strominger, J. W. Yewdell, and A. Porgador. 2001. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409:1055-1060. (Pubitemid 32204059)
28. Mark, K. E., L. Corey, T. C. Meng, A. S. Magaret, M. L. Huang, S. Selke, H. B. Slade, S. K. Tyring, T. Warren, S. L. Sacks, P. Leone, V. A. Bergland, and A. Wald. 2007. Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trial. J. Infect. Dis. 195:1324-1331.
29. Moraes, M. P., J. Chinsangaram, M. C. Brum, and M. J. Grubman. 2003. Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine. Vaccine 22:268-279. (Pubitemid 37412269)
30. Moraes, M. P., T. de Los Santos, M. Koster, T. Turecek, H. Wang, V. G. Andreyev, and M. J. Grubman. 2007. Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons. J. Virol. 81:7124-7135. (Pubitemid 46986648)
31. Mori, S., A. Jewett, M. Cavalcanti, K. Murakami-Mori, S. Nakamura, and B. Bonavida. 1998. Differential regulation of human NK cell-associated gene expression following activation by IL-2, IFN-α and PMA/ionomycin. Int. J. Oncol. 12:1165-1170.
32. Nfon, C. K., G. S. Ferman, F. N. Toka, and W. T. Golde. 2008. Inhibition of interferon alpha from circulating dendritic cells by foot-and-mouth disease virus (FMDV) during acute infection. Viral Immunol. 21:68-77.
33. Pintaric, M., W. Gerner, and A. Saalmuller. 2008. Synergistic effects of IL-2, IL-12 and IL-18 on cytolytic activity, perforin expression and IFN-γ production of porcine natural killer cells. Vet. Immunol. Immunopathol. 121:68-82.
34. Pirhonen, J., T. Sareneva, I. Julkunen, and S. Matikainen. 2001. Virus infection induces proteolytic processing of IL-18 in human macrophages via caspase-1 and caspase-3 activation. Eur. J. Immunol. 31:726-733.
35. Pompei, L., S. Jang, B. Zamlynny, S. Ravikumar, A. McBride, S. P. Hickman, and P. Salgame. 2007. Disparity in IL-12 release in dendritic cells and macrophages in response to Mycobacterium tuberculosis is due to use of distinct TLRs. J. Immunol. 178:5192-5199.
36. Roda, J. M., R. Parihar, and W. E. Carson III. 2005. CpG-containing oligodeoxynucleotides act through TLR9 to enhance the NK cell cytokine response to antibody-coated tumor cells. J. Immunol. 175:1619-1627. (Pubitemid 41023064)
37. Sawaki, J., H. Tsutsui, N. Hayashi, K. Yasuda, S. Akira, T. Tanizawa, and K. Nakanishi. 2007. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways. Int. Immunol. 19:311-320.
38. Scheel, B., R. Teufel, J. Probst, J. P. Carralot, J. Geginat, M. Radsak, D. Jarrossay, H. Wagner, G. Jung, H. G. Rammensee, I. Hoerr, and S. Pascolo. 2005. Toll-like receptor-dependent activation of several human blood cell types by protamine-condensed mRNA. Eur. J. Immunol. 35:1557-1566.
39. + cells after toll-like receptor 7/8 triggering. PLoS ONE 3:e1999.
40. Seya, T., T. Akazawa, J. Uehori, M. Matsumoto, I. Azuma, and K. Toyoshima. 2003. Role of toll-like receptors and their adaptors in adjuvant immunotherapy for cancer. Anticancer Res. 23:4369-4376. (Pubitemid 37474889)
41. Sivori, S., S. Carlomagno, L. Moretta, and A. Moretta. 2006. Comparison of different CpG oligodeoxynucleotide classes for their capability to stimulate human NK cells. Eur. J. Immunol. 36:961-967.
42. Stary, G., C. Bangert, M. Tauber, R. Strohal, T. Kopp, and G. Stingl. 2007. Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells. J. Exp. Med. 204:1441-1451.
43. Summerfield, A., L. Guzylack-Piriou, A. Schaub, C. P. Carrasco, V. Tache, B. Charley, and K. C. McCullough. 2003. Porcine peripheral blood dendritic cells and natural interferon-producing cells. Immunology 110:440-449. (Pubitemid 37521874)
44. Toka, F. N., C. K. Nfon, H. Dawson, D. Mark Estes, and W. T. Golde. 2009. Activation of porcine natural killer (NK) cells and lysis of foot-and-mouth disease virus (FMDV) infected cells. J. Interferon Cytokine Res. 29:179-192.
45. Trinchieri, G., and A. Sher. 2007. Cooperation of Toll-like receptor signals in innate immune defence. Nat. Rev. Immunol. 7:179-190.
46. Tsujimoto, H., T. Uchida, P. A. Efron, P. O. Scumpia, A. Verma, T. Matsumoto, S. K. Tschoeke, R. F. Ungaro, S. Ono, S. Seki, M. J. Clare-Salzler, H. V. Baker, H. Mochizuki, R. Ramphal, and L. L. Moldawer. 2005. Flagellin enhances NK cell proliferation and activation directly and through dendritic cell-NK cell interactions. J. Leukoc. Biol. 78:888-897.
47. Ulevitch, R. J. 2004. Therapeutics targeting the innate immune system. Nat. Rev. Immunol. 4:512-520.
48. Weck, M. M., F. Grunebach, D. Werth, C. Sinzger, A. Bringmann, and P. Brossart. 2007. TLR ligands differentially affect uptake and presentation of cellular antigens. Blood 109:3890-3894. (Pubitemid 46641741)
49. Zhang, B., J. Zhang, and Z. Tian. 2008. Comparison in the effects of IL-2, IL-12, IL-15 and IFN-α on gene regulation of granzymes of human NK cell line NK-92. Int. Immunopharmacol. 8:989-996.
50. Zhang, Y., Y. Guo, K. Lv, K. Wang, and S. Sun. 2008. Molecular cloning and functional characterization of porcine toll-like receptor 7 involved in recognition of single-stranded RNA virus/ssRNA. Mol. Immunol. 45:1184-1190.